Trandolapril; Verapamil Hydrochloride Patent Expiration
Trandolapril; Verapamil Hydrochloride was first introduced by Abbvie Inc
Trandolapril; Verapamil Hydrochloride Patents
Given below is the list of patents protecting Trandolapril; Verapamil Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tarka | US5721244 | Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
Feb 24, 2015
(Expired) | Abbvie |
Trandolapril; Verapamil Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Trandolapril; Verapamil Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Trandolapril; Verapamil Hydrochloride.
Given below is the list of companies who have filed for Trandolapril; Verapamil Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Trandolapril; Verapamil Hydrochloride. All of these versions come by the name TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4MG; 240MG
(reference standard) | tablet, extended release | Prescription | ORAL | N/A | May 5, 2010 |
| 2MG; 180MG | tablet, extended release | Prescription | ORAL | N/A | May 26, 2010 |
| 2MG; 240MG | tablet, extended release | Prescription | ORAL | N/A | May 26, 2010 |
| 1MG; 240MG | tablet, extended release | Prescription | ORAL | N/A | Aug 30, 2010 |